Cisplatin and zoledronic acid: two drugs combined in a Pt(ii ) complex with potential antitumor activity towards bone tumors and metastases
Dalton Transactions（2023）
摘要
Two drugs already approved by the U.S. Food and Drug Administration and the European Medicinal Agency combined in a dinuclear Pt( ii ) complex.
更多查看译文
关键词
zoledronic acid,cisplatin,bone tumors,potential antitumor activity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要